Evidence map›Paper›PMID 30326576›Full record

ArticleHealthcare (Basel, Switzerland)2018

Under-Detection of Lyme Disease in Canada.

Vett K Lloyd, Ralph G Hawkins

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Understanding the Perspectives, Experiences, Beliefs, and Knowledge of Health Care Practitioners on the Diagnosis and Treatment of Lyme Disease in Canada.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2025
    Article
  4. Article
  5. Article
  6. Antibodies toMicrobiology spectrum · 2024
    Observational
  7. Article
  8. Cholesterol Contributes to Risk, Severity, and Machine Learning-Driven Diagnosis of Lyme Disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Monitoring Risk: Tick andPathogens (Basel, Switzerland) · 2021
    Article
  16. Modelling Spatiotemporal Patterns of Lyme Disease Emergence in Québec.International journal of environmental research and public health · 2021
    Article
  17. Article
  18. Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease.Clinical, cosmetic and investigational dermatology · 2021
    Article
  19. Human and Veterinary Vaccines for Lyme Disease.Current issues in molecular biology · 2021
    Article
  20. Microbiome Composition andTropical medicine and infectious disease · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vett K LloydDepartment Biology, Mt. Allison University, Sackville, NB E4L 1E2, Canada. vlloyd@mta.ca.
Ralph G HawkinsDivision of General Internal Medicine, University of Calgary, South Health Campus, Calgary, AB T3M 1M4, Canada. rghawkin@ucalgary.ca.

Funding

Canadian Lyme disease Foundation 101327Natural Sciences and Engineering Research Council of Canada 2015-04426
6 · The paper itself

Abstract

Lyme disease arises from infection with pathogenic

Indexed as

C6 ELISACanadacanine seroprevalenceimmunoblottingLyme diseaseLyme disease incidenceLyme disease prevalencetickstick surveillanceWCS ELISA

Identifiers

PMID30326576
PMCPMC6315539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.